Characterization and molecular mechanistic study of a therapeutic peptide functionalized nanobioconjugate inhibiting the p53-HDM2 interaction in Retinoblastoma

ABSTRACT: Prepared peptide conjugate nanoparticles for retinoblastoma cancer therapy

ORGANISM(S): Homo sapiens

PROVIDER: GSE92987 | GEO | 2017/12/27

SECONDARY ACCESSION(S): PRJNA359214

REPOSITORIES: GEO